Author:
Yankov Georgi,Aleksieva Magdalena,Keltchev Asen,Mekov Evgeni
Abstract
Inflammatory Myofibroblastic Tumor (IMT) is an exceptionally uncommon benign tumor. We present a 54-year-old man with IMT, frequent episodes of respiratory infections, aspergillosis, and hemoptysis, who has received 23 years of conservative treatment. A successful left intrapericardial pneumonectomy was performed. During chest closure, the left atrial auricle lesion caused a massive hemorrhage owing to contact with the staplers of the left pulmonary artery stapler line. The bleeding was immediately controlled. One year after surgery, the patient has fully recovered and no adverse events or relapses have occurred.
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference10 articles.
1. World Health Organization (WHO). Soft tissue and bone tumors. WHO classification of tumors, 5th edition, volume 3. 2013. Available from: https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/Soft-Tissue-And-Bone-Tumours-2020
2. Braham Y, Migaou A, Njima M, et al. Inflammatory myofibroblastic tumor of the lung: A rare entity. Respiratory Medicine Case Reports 2020;31:101287.
3. Iyer A, Radonic T, Hecamp LC, et al. Inflammatory myofibroblastic tumor of the central airways: treatment and molecular analysis. ERJ open research 2021;7:00151-2020.
4. Yüksel C, Yenigün BM, Kocaman G, et al. Operated pulmonary inflammatory myofibroblastic tumors: Our experience with 17 cases. Turk Gogus Kalp Damar Cerrahisi Derg 2022;30:101-8.
5. Hammas N, Chbani L, Rami M, et al. A rare tumor of the lung: inflammatory myofibroblastic tumor. Diagnostic Pathology 2012;7:83.